Authors: Hozjan, Viktorija; Guo, Kunde; Wu, Xiaoqiu; Oppermann, Udo

Source: Expert Review of Proteomics, Volume 5, Number 1, February 2008 , pp. 137-143(7)

Publisher: Expert Reviews

Abstract:

Ligand interactions are central to enzyme or receptor function, constituting a cornerstone in biochemistry and pharmacology. Here we discuss a ligand application that can be exploited to significantly increase the proportion of recombinant protein expressed in soluble form, by including ligands during the culture. Provided that a sufficiently soluble, cell-permeable and avid ligand is available, one can use it to stabilize nascently synthesized proteins, and in this manner promote solubility and prevent aggregation. To our knowledge, this concept has not been explored systematically and we provide here the first data on ligand supplementation in expression experiments across a whole human protein family: the short-chain dehydrogenases/reductases (SDR). We identified glycerrhitinic acid and its hemisuccinate ester, carbenoxolone (CBX), as ligands with variable affinities ranging from low nanomolar to micromolar binding constants against several SDRs. CBX was utilized as a culture additive in Escherichia coli expression systems against a total of approximately 500 constructs derived from 65 SDR targets, and significantly higher levels of soluble protein were obtained for more than four distinct targets. One of these, the glucocorticoid-activating enzyme type 1 11-hydroxysteroid dehydrogenase (11-HSD1), was solubly expressed only at a very low level (<10 g/l culture) in the absence of ligand; however, soluble expression could be enhanced to mg/l levels by inclusion of CBX or other inhibitors. Other compounds with different chemical scaffolds were used against 11-HSD1 in equivalent expression experiments yielding similar results. Taken together, if suitable ligands for a given protein are available, this approach could be tested quickly and might represent an easy and effective strategy to enhance soluble protein production, suitable for structural and functional characterization studies.

Keywords: 11-hydroxysteroid dehydrogenase; carbenoxolone; heterologous expression; ligand supplementation; protein production; structural genomics

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14789450.5.1.137

Affiliations: 1: Structural Genomics Consortium, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, UK., Email: viktorija.hozjan@sgc.ox.ac.uk

Publication date: 2008-02-01

More about this publication?

• Expert Review of Proteomics explores technologies, methods and discoveries from the field of proteomics to advance scientific understanding of the many varied roles protein expression plays in human health and disease.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Biology
• By this author: Hozjan, Viktorija ;  Guo, Kunde ;  Wu, Xiaoqiu ;  Oppermann, Udo

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers